159 related articles for article (PubMed ID: 33017423)
1. International consensus validation of the POPI tool (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions) to identify inappropriate prescribing in pediatrics.
Sadozai L; Sable S; Le Roux E; Coste P; Guillot C; Boizeau P; Berthe-Aucejo A; Angoulvant F; Lorrot M; Bourdon O; Prot-Labarthe S
PLoS One; 2020; 15(10):e0240105. PubMed ID: 33017423
[TBL] [Abstract][Full Text] [Related]
2. POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify inappropriate prescribing.
Prot-Labarthe S; Weil T; Angoulvant F; Boulkedid R; Alberti C; Bourdon O
PLoS One; 2014; 9(6):e101171. PubMed ID: 24978045
[TBL] [Abstract][Full Text] [Related]
3. [Consensus validation of a tool to identify inappropriate prescribing in pediatrics (POPI)].
Prot-Labarthe S; Weil T; Nguyen NP; Berthe-Aucejo A; Angoulvant F; Boulkedid R; Alberti C; Bourdon O
Arch Pediatr; 2016 May; 23(5):481-90. PubMed ID: 27067037
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of irrational prescribing in French paediatric hospital: prevalence of inappropriate prescription detected by Pediatrics: Omission of Prescription and Inappropriate prescription (POPI) in the emergency unit and in the ambulatory setting.
Berthe-Aucejo A; Nguyen PKH; Angoulvant F; Bellettre X; Albaret P; Weil T; Boulkedid R; Bourdon O; Prot-Labarthe S
BMJ Open; 2019 Mar; 9(3):e019186. PubMed ID: 30898791
[TBL] [Abstract][Full Text] [Related]
5. Expert Consensus on a List of Inappropriate Prescribing after Prescription Review in Pediatric Units in Abidjan, Côte d'Ivoire.
Doffou E; Avi C; Yao KC; Abrogoua DP
Integr Pharm Res Pract; 2021; 10():79-91. PubMed ID: 34476206
[TBL] [Abstract][Full Text] [Related]
6. Interrater reliability of a tool to assess omission of prescription and inappropriate prescriptions in paediatrics.
Berthe-Aucejo A; Nguyen NPKK; Angoulvant F; Boulkedid R; Bellettre X; Weil T; Alberti C; Bourdon O; Prot-Labarthe S
Int J Clin Pharm; 2019 Jun; 41(3):734-740. PubMed ID: 30972535
[TBL] [Abstract][Full Text] [Related]
7. Assessment of prescribing in under-five paediatric outpatients in Nigeria: an application of the POPI (Pediatrics: Omission of Prescription and Inappropriate Prescription) tool.
Ahwinahwi US; Odili VU; Nwachukwu DO
Int J Pharm Pract; 2024 Feb; 32(1):76-82. PubMed ID: 37935629
[TBL] [Abstract][Full Text] [Related]
8. Tools for Identifying Potentially Inappropriate Prescriptions for Children and Their Applicability in Clinical Practices: A Systematic Review.
Li S; Huang L; Chen Z; Zeng L; Li H; Diao S; Jia ZJ; Cheng G; Yu Q; Zhang L
Front Pharmacol; 2022; 13():787113. PubMed ID: 35662686
[No Abstract] [Full Text] [Related]
9. Paediatric Rational Prescribing: A Systematic Review of Assessment Tools.
Corrick F; Conroy S; Sammons H; Choonara I
Int J Environ Res Public Health; 2020 Feb; 17(5):. PubMed ID: 32106497
[TBL] [Abstract][Full Text] [Related]
10. Potentially inappropriate prescribing in an Irish elderly population in primary care.
Ryan C; O'Mahony D; Kennedy J; Weedle P; Byrne S
Br J Clin Pharmacol; 2009 Dec; 68(6):936-47. PubMed ID: 20002089
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of explicit criteria to identify potentially inappropriate prescribing for adults with type 2 diabetes mellitus.
Ayalew MB; Dieberg G; Quirk F; Spark MJ
Res Social Adm Pharm; 2022 Jun; 18(6):2989-2996. PubMed ID: 34330635
[TBL] [Abstract][Full Text] [Related]
12. [Development of a tool to help optimizing drug prescriptions in pediatric units in Côte d'Ivoire: GOPP tool].
Doffou E; Kamenan BA; Abrogoua DP
Ann Pharm Fr; 2022 May; 80(3):340-362. PubMed ID: 34656545
[TBL] [Abstract][Full Text] [Related]
13. PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique.
Barry E; O'Brien K; Moriarty F; Cooper J; Redmond P; Hughes CM; Bennett K; Fahey T; Smith SM;
BMJ Open; 2016 Sep; 6(9):e012079. PubMed ID: 27601499
[TBL] [Abstract][Full Text] [Related]
14. A tool for screening potentially inappropriate prescribing in Chinese children.
Li S; Huang L; Zeng L; Yu D; Jia ZJ; Cheng G; Zhang L
Front Pharmacol; 2022; 13():1019795. PubMed ID: 36386167
[No Abstract] [Full Text] [Related]
15. TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities.
Lonchampt S; Gerber F; Aubry JM; Desmeules J; Besson M; Kosel K
BMJ Open; 2020 Nov; 10(11):e039208. PubMed ID: 33148748
[TBL] [Abstract][Full Text] [Related]
16. Older patients' prescriptions screening in the community pharmacy: development of the Ghent Older People's Prescriptions community Pharmacy Screening (GheOP³S) tool.
Tommelein E; Petrovic M; Somers A; Mehuys E; van der Cammen T; Boussery K
J Public Health (Oxf); 2016 Jun; 38(2):e158-70. PubMed ID: 26175537
[TBL] [Abstract][Full Text] [Related]
17. International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study.
Bahat G; Ilhan B; Erdogan T; Oren MM; Karan MA; Burkhardt H; Denkinger M; Garfinkel D; Cruz-Jentoft AJ; Morrissey Y; Onder G; Pazan F; Tommelein E; Topinkova E; van der Velde N; Petrovic M
Drugs Aging; 2021 Jun; 38(6):513-521. PubMed ID: 33847948
[TBL] [Abstract][Full Text] [Related]
18. The Norwegian General Practice--Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study.
Nyborg G; Straand J; Klovning A; Brekke M
Scand J Prim Health Care; 2015 Jun; 33(2):134-41. PubMed ID: 26100966
[TBL] [Abstract][Full Text] [Related]
19. Two-round Delphi technique for the consensual design of a paediatric pharmaceutical care model.
Fernández-Llamazares CM; Hernández-Gago Y; Pozas M; Cabañas MJ; Feal B; Villaronga M; Alvarez-Del-Vayo C; Valverde E
Pharmacol Res; 2013 Feb; 68(1):31-7. PubMed ID: 23153856
[TBL] [Abstract][Full Text] [Related]
20. Development of a consensus-base list of criteria for prescribing medication in a pediatric population.
Guérin A; Bussières JF; Boulkedid R; Bourdon O; Prot-Labarthe S
Int J Clin Pharm; 2015 Oct; 37(5):883-94. PubMed ID: 26017398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
